| More

The use of synthetic colloids in dogs and cats

Views: 268 Downloads: 276
Ι. SAVVAS (Ι. ΣΑΒΒΑΣ), Α. PAPASTEFANOU (Α. ΠΑΠΑΣΤΕΦΑΝΟΥ), Τ. ANAGNOSTOU (Τ. ΑΝΑΓΝΩΣΤΟΥ)
Ι. SAVVAS (Ι. ΣΑΒΒΑΣ), Α. PAPASTEFANOU (Α. ΠΑΠΑΣΤΕΦΑΝΟΥ), Τ. ANAGNOSTOU (Τ. ΑΝΑΓΝΩΣΤΟΥ)

Abstract


It is common in small animal clinical practice to administer fluids in order to replace water deficits or to treat diseases. One of the indications of the fluid therapy is treatment of low intravascular volume, which begins with crystalloid administration. Colloids, however, are more effective in maintaining intravascular volume than crystalloid solutions, because they contain high molecular weight molecules that do not cross capillary walls. As a result, plasma oncotic pressure increases, resulting in water transfer from the interstitial to the intravascular space. The administered volume of a colloid is equal or slightly bigger than the required replacement volume, and the total volume administered is lower than the required volume of a crystalloid. Therefore, colloids should be considered when a patient does not appear to be responding appropriately to the crystalloid fluid infusion or when oedema develops prior to adequate blood volume restoration. The most common side effects of colloid administration may be volume overload, anaphylactic reaction, renal toxicity and coagulation disorders. Colloids are natural and synthetic. Natural colloids include whole blood, plasma and blood products. Synthetic colloids are dextrans, gelatins and starches.

Haemoglobine-based oxygen carriers may improve oxygenation and act as colloids. Dextrans have a mean molecular weight of either 40,000 or 70,000 daltons. They have a short half-life and may cause coagulation defeciencies, anaphylactic reactions or acute renal failure. Gelatins have a shorter half-life. Starches are glucose polymers with glycosidic bonds and hydroxyl-ethyl groups.

According to the number of these groups, they are distinguished in three types: hetastrach, tetrastarch and pentastarch. They have oncotic effects, long half-life and few side effects. Colloids are mainly administered in shock, as well as in hypoproteinaemia, sepsis and third space losses. They are always co-administered with crystalloids, in order to replace interstitial water as well. Water loss replacement is treated in three phases. Initially, intravascular volume is restored (resuscitation phase), then interstitial space is hydrated (rehydration phase) and finally cells are hydrated (maintenance phase). Depending on the underlying disease, different combinations of crystalloids and colloids are used. Special attention is needed in cases of internal haemorrhage, increased endothelial permeability and hypoproteinaemia.


Keywords


Colloids; dog; cat

Full Text:

PDF

References


Adamantos S and Hughes D (2008) Fluid Therapy in patients with Pulmonary Disease. Vet Clin North Am Small Anim Pract, 38:719-725.

Boag A (2009) Colloids: The European advantage, use of differentsynthetic colloids. In: Proceedings of the 8th EVECCS Congress, (Berlin) Germany, pp. 21-24.

Broadstone RV (1999) Fluid Therapy and Newer Blood Products. Vet Clin North Am Small Anim Pract, 29:611-628.

Bunn F, Trivedi D, Ashraf S (2008) Colloid solutions for fluid resuscitation. Cochrane Database of Systematic Reviews, Issue 1. Art.No.:CD001319.

Chan DL, Rozanski EA, Freeman LM, Rush JE (2001) Colloid Osmotic Pressure in Health and Disease. Comped Contin Educ Pract Vet, 23:896-903.

Chan DL (2008) Colloids: Current Recommendations. Vet Clin NorthAm Small Anim Pract, 38:587-593.

Devey JJ (2002) Fluid Resuscitation in Shock. In: Proceedings of the EVECCS Congress, (Amsterdam) The Netherlands, pp. 62-68.

Driessen Β and Brainard B. (2006) Fluid therapy for the traumatized patient. JVetEmerg Cut Care 16:276-299.

Friedman Z, Berkenstadt H, Preisman S, Azriel Perei A (2003) A Comparison of Lactated Ringer's Solution to Hydroxyethyl Starch 6% in a Model of Severe Hemorrhagic Shock and Continuous Bleeding in Dogs. AnesthAnalg, 96:39-45.

Gibson GR, Callan MB, Hoffman V, Giger U (2002) Use of hemoglobin-based oxygen-carrying solution in cats: 72 cases (1982-2000)./^m Vet Med Assoc, 221:96-102.

Glowaski MM, DVM, Moon-Massat PF, Erb ΗΝ, Barr SC (2003) Effects of oxypolygelatin and dextran-70 on hemostatic variables in dogs. Vet Anaesth Anaig, 30:202-210.

Haskins SC (2002) Shock - Recognition and Treatment. In: Proceedings of the EVECCS Congress, (Amsterdam) The Netherlands, pp. 17-44.

Heier HE, Bugge W, Hjelmeland K, S0reide E, S0rlie D, Haheim LL (2006) Transfusion vs. alternative treatment modalities in acute bleeding: a systematic TQviQw.ActaAnaesthesiolScand, 50:920-931.

Hughes D (2000) Transvascular fluid dynamics. Vet Anaesth Analg, 27:63-69.

Hughes D (2001) Fluid therapy with artificial colloids: complications and controversies. Vet Anaesth Analg, 28:111-118.

Ketekidou E and Tsirogianni A (2002) Intravenous fluids and electrolytes. In: Principles of Perioperative Medicine. University Studio Press, Thessaloniki.

Mathews KA (1998) The Various Types of Parenteral Fluids and Their Indications. Vet Clin North Am Small Anim Pract, 28:483-513.

Mathews KA (2009) Complications of fluid therapy. In: Proceedings of the 8th EVECCS Congress, (Berlin) Germany, pp. 25-28.

Mensack S (2008) Fluid Therapy: Options and Rational Administration. Vet Clin North Am Small Anim Pract, 38:575-586.

Moon-Massat PF (2007) Fluid therapy and blood transfusion. In: Manual of Canine and Feline Anaesthesia and Analgesia. BS A VA, Gloucester, pp. 166-182.

Moore FA, McKinley ΒΑ, Moore EE (2004) The next generation in shock resuscitation. Lancet, 363:1988-1996.

Pachtinger GE and Drobatz Κ (2008) Assessment and Treatment of Hypovolemic States. Vet Clin North Am Small Anim Pract, 38:629-643.

Pascoe PJ (2006) Perioperative management of fluid therapy. In: Fluid, electrolyte and acid-base disorders in small animal practice. SaundersElsevier, St. Louis, pp. 391-419.

Raffe M (2000) Medical Use of Colloids. In: Kirk's Current Veterinary Therapy XIII Small Animal Practice. W.B. Saunders, Philadelphia, pp. 66-69.

Rudloff E and Kirby R (2000) Colloids: Current Recommendations. In: Kirk's Current Veterinary Therapy XIII Small Animal Practice. W.B. Saunders, Philadelphia, pp. 131-136.

Rudloff E and Kirby R (2001) Colloid and Crystalloid Resuscitation. Vet Clin North Am Small Anim Pract, 31:1207-1229.

Rudloff E and Kirby R (2008) Fluid Resuscitation and the Trauma Patient. Vet Clin North Am Small Anim Pract, 38:645-652.

Seeler DC (2007) Fluid, Electrolyte and Blood Component Therapy. In: Lumb & I ones' Veterinary Anaesthesia. 4th edn, Williams & Wilkins, Baltimore, pp. 185-201.

Waikar and Chertow (2000) Crystalloids versus colloids for resuscitation in shock. Curr Opin NephrolHypertens, 9:501-504.

Wellman ML, DiBartola SP, Kohn CW (2006) Applied Physiology of Body Fluids in Dogs and Cats. In: Fluid, electrolyte and acid-base disorders in small animal practice. 3rd edn, Saunders Elsevier, St. Louis, pp. 3-25.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 SAVVAS I, PAPASTEFANOU A, ANAGNOSTOU T

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.